Oct. 23 at 11:22 PM
$KVUE this stock is dead in the water after the double hits of false and scientifically unfounded Tylenol/autism claims, plus the news of a UK class action lawsuit for damages arising from cancer allegedly caused by the use of talc-based baby powder. A rational assessment of the *actual* potential liability from these two categories of claims shows that the
$15B lopped off the market cap is wildly excessive. The overreaction is driven by fear, headlines, algos, and of course Trump pounding the table that Tylenol causes autism. He probably thinks he should now get the Nobel prize in medicine for preventing autism. It is, of course, nonsense. So, buy when others are fearful; at
$15/share you’re getting some of the best consumer brands at a 30-40% discount to fair value.
